Rigel Pharmaceuticals (RIGL) Change in Acquisitions & Divestments (2016 - 2025)
Rigel Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 16 years, most recently at $13.5 million for Q4 2025.
- For Q4 2025, Change in Acquisitions & Divestments rose 100.73% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $61.1 million, up 53.98%, while the annual FY2025 figure was $61.1 million, 53.98% up from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 was $13.5 million at Rigel Pharmaceuticals, down from $20.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $30.8 million in Q4 2021 and troughed at $1.4 million in Q3 2021.
- A 5-year average of $15.3 million and a median of $14.6 million in 2023 define the central range for Change in Acquisitions & Divestments.
- Biggest five-year swings in Change in Acquisitions & Divestments: plummeted 96.54% in 2021 and later soared 2002.72% in 2022.
- Year by year, Change in Acquisitions & Divestments stood at $30.8 million in 2021, then tumbled by 31.39% to $21.2 million in 2022, then crashed by 71.65% to $6.0 million in 2023, then increased by 12.5% to $6.8 million in 2024, then surged by 100.73% to $13.5 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for RIGL at $13.5 million in Q4 2025, $20.7 million in Q3 2025, and $15.8 million in Q2 2025.